SSY GROUP (02005.HK): Trustee purchases 1,000,000 shares under restricted share award scheme for approximately HKD 2.73 million
NewTimeSpace News: On 1 September 2026, SSY Group Limited (stock code: 02005) announced that, pursuant to the restricted share award scheme adopted by the Company on 27 December 2018 and funded by the Company's internal resources, the trustee of the scheme purchased an aggregate of 1,000,000 shares of the Company on the open market, holding such shares in trust for the selected participants under the scheme.
According to the announcement, the average consideration per share purchased (excluding expenses) was approximately HKD 2.7306, and the total consideration paid for the shares purchased (excluding expenses) was approximately HKD 2,730,600, representing approximately 0.034% of the total number of currently issued shares. Immediately after the purchase, the balance of shares held by the trustee was 14,180,000 shares, representing approximately 0.480% of the total number of currently issued shares.
The board of directors will from time to time review and, at its absolute discretion, decide the number of shares to be granted to the selected participants.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- SSY GROUP (02005.HK): Trustee Purchases 900,000 Shares for Approximately HKD 2,414,700 under Restricted Share Award Scheme
- SSY GROUP (02005.HK): Gadobutrol injection and indocyanine green for injection approved, enhancing imaging and critical care product portfolio
- SSY GROUP(02005.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 320.32 million, YoY increase of 12.99%
- SSY GROUP (02005.HK): Obtains production registration approval for sodium ozagrel injection, achieving full dosage form coverage
- SSY GROUP (02005.HK): Vitamin K1 Injection obtains NMPA drug production registration certificate, deemed to pass consistency evaluation